Citius Oncology, Inc. (CTOR) vs Sofgen Pharma S.A (PROCF)
Citius Oncology, Inc. and Sofgen Pharma S.A are both Drug Manufacturers Specialty & Generic companies. Sofgen Pharma S.A is the larger, with a market value of $114.0M against $97.6M — 1.2× the size. Sofgen Pharma S.A has the higher net margin (9.52% vs 0.00%) and the higher return on invested capital (15.2% vs −67.2%). Across the 12 metrics below, Sofgen Pharma S.A leads on 9 and Citius Oncology, Inc. on 3.
Valuation
Profitability
| Metric | CTOR | PROCF | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | — | 56.16% | 53.94% |
| Operating margin | 0.00% | 17.01% | 0.00% |
| Net margin | 0.00% | 9.52% | 0.00% |
| Free cash flow margin | 0.00% | 17.66% | 0.00% |
| Return on equity | (126.58%) | (213.06%) | (0.40%) |
| Return on assets | (45.20%) | 8.82% | (3.32%) |
| Return on invested capital | (67.15%) | 15.21% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack